Professional
Added to YB: 2024-08-02
Pitch date: 2024-06-30
RMD [bullish]
ResMed Inc.
+22.23%
current return
Author Info
No bio for this author
Company Info
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.
Market Cap
$31.7B
Pitch Price
$186.90
Price Target
N/A
Dividend
1.20%
EV/EBITDA
14.48
P/E
21.09
EV/Sales
5.50
Sector
Health Care Equipment and Supplies
Category
value
Auscap Asset Management Portfolio Holding: ResMed Inc.
RMD: CPAP leader, 15% EPS CAGR, 20%+ ROE. GLP-1 concerns overblown; study shows 10.5% higher PAP therapy initiation for GLP-1 users. CPAP remains preferred, immediate benefits vs. GLP-1's 52-week timeline. Strong demand, 1B potential market, 23.5M devices. Trading at discount to historical P/E. Significant growth runway ahead.
Read full article (2 min)